Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025.
Pfizer Invites Investors and the Public Invite to Watch and Listen Global President and Oncologist Andy Bumpers and Senior Vice President Chris Boshoff, Head of Immunology Oncology, Early Development and Translational Oncology, Online Presentation